Unknown

Dataset Information

0

In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies.


ABSTRACT: Imaging with labeled monoclonal antibodies may be useful in detecting, staging, and monitoring tumors. Despite their high affinity and specificity, a critical limitation of antibody imaging is the high background signal due to prolonged clearance from the blood, which reduces the tumor-to-background ratio. To address this problem, we developed a molecular imaging probe consisting of multiple self-quenching fluorophores [Cy5.5 or Alexa Fluor 680 (Alexa680)] conjugated to a monoclonal antibody (trastuzumab) to synthesize Tra-Cy5.5(SQ) or Tra-Alexa680(SQ), respectively. This agent only becomes fluorescently "active" after cellular internalization but is quenched in the unbound state leading to high tumor-to-background ratios. The in vitro quenching capacity for both conjugates was approximately 9-fold. In vivo imaging experiments were done in mice bearing both 3T3/HER-2+ and BALB/3T3/ZsGreen/HER-2- xenografts. Tra-Alexa680(SQ) produced specific enhancement in the 3T3/HER-2+ tumors but not in the HER-2- control tumors. However, Tra-Cy5.5(SQ) produced nonspecific enhancement in both 3T3/HER-2+ and control tumors. In conclusion, whereas Cy5.5-conjugates produced nonspecific results as well as rapid liver accumulation, conjugating multiple Alexa680 molecules to a single monoclonal antibody resulted in a near-infrared optical agent that activated within specific target tumors with high tumor-to-background ratio with considerable potential for clinical translation.

SUBMITTER: Ogawa M 

PROVIDER: S-EPMC2790275 | biostudies-literature | 2009 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies.

Ogawa Mikako M   Regino Celeste A S CA   Choyke Peter L PL   Kobayashi Hisataka H  

Molecular cancer therapeutics 20090101 1


Imaging with labeled monoclonal antibodies may be useful in detecting, staging, and monitoring tumors. Despite their high affinity and specificity, a critical limitation of antibody imaging is the high background signal due to prolonged clearance from the blood, which reduces the tumor-to-background ratio. To address this problem, we developed a molecular imaging probe consisting of multiple self-quenching fluorophores [Cy5.5 or Alexa Fluor 680 (Alexa680)] conjugated to a monoclonal antibody (tr  ...[more]

Similar Datasets

| S-EPMC7331221 | biostudies-literature
| S-EPMC3618996 | biostudies-literature
| S-EPMC5030170 | biostudies-literature
| S-EPMC7512024 | biostudies-literature
| S-EPMC5059626 | biostudies-literature
| S-EPMC2788996 | biostudies-literature
| S-EPMC5842124 | biostudies-literature
| S-EPMC9266996 | biostudies-literature
| S-EPMC6978336 | biostudies-literature
| S-EPMC4575640 | biostudies-literature